Bcl-2 Family Proteins as Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3132-3148
Author(s):
Peter E. Czabotar and Guillaume Lessene
Updates of mTOR Inhibitors
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
571-581
Author(s):
Hongyu Zhou, Yan Luo and Shile Huang
The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Journal:
Current Protein & Peptide Science
Volume:
11
Page:
459-470
Author(s):
Di Chen and Q. Ping Dou
Tyrosine Kinase Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
462-483
Author(s):
C. Natoli, B. Perrucci, F. Perrotti, L. Falchi and S. Iacobelli
The mTOR Pathway: A New Target in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
484-495
Author(s):
L. Ciuffreda, C. Di Sanza, U.C. Incani and M. Milella
Clinical Advances in Hypomethylating Agents Targeting Epigenetic Pathways
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
539-545
Author(s):
S. Cang, Q. Lu, Y. Ma and D. Liu
Monoclonal Antibody Therapy in Haematological Malignancies
Journal:
Current Clinical Pharmacology
Volume:
5
Page:
148-159
Author(s):
Martine E.D. Chamuleau, Arjan A. van de Loosdrecht and Peter C. Huijgens
Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment
Journal:
Current Clinical Pharmacology
Volume:
5
Page:
196-208
Author(s):
Jan H. Beumer and Hussein Tawbi
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Journal:
Current Drug Targets
Volume:
11
Page:
1000-1017
Author(s):
Gang Niu and Xiaoyuan Chen
Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development
Journal:
Current Molecular Medicine
Volume:
10
Page:
596-607
Author(s):
S. Mizuarai, H. Irie and H. Kotani